Critical Care & Emergencies (all articles)
Extracorporeal treatment for poisoning to beta-adrenergic antagonists: systematic review and recommendations from the EXTRIP workgroup.
14 Jun, 2021 | 08:27h | UTC
Non-invasive oxygenation strategies for respiratory failure with COVID-19: A concise narrative review of literature in pre and mid-COVID-19 era.
11 Jun, 2021 | 08:25h | UTC
CDC says heart inflammation cases were higher than expected in 16- to 24-year-olds after second Covid vaccine shot, but still rare.
11 Jun, 2021 | 08:28h | UTCSee also: CDC plans “emergency meeting” on rare heart inflammation following COVID-19 vaccines – CBC News
Related: Israel reports link between rare cases of heart inflammation and COVID-19 vaccination in young men.
RCT: In patients with atrial fibrillation or mechanical heart valves treated with warfarin undergoing surgery, postoperative bridging treatment with low molecular weight heparin did not prevent major thromboembolism.
11 Jun, 2021 | 08:19h | UTC
Commentary on Twitter
P-E-R-S-E-V-E-R-A-N-C-E = 15 yrs from start to BMJ publication. Bottom line: in pts with atrial fibrillation or mechanical heart valves who had warfarin interrupted for a procedure, we found no benefit of
postop LMWH bridging to prevent major
thromboembolism @canvector @CIHR_ICRH https://t.co/9z0XTQgsbA— Professor Susan R Kahn (@SusanRKahn1) June 10, 2021
M-A: Safety of thoracentesis and tube thoracostomy in patients with uncorrected coagulopathy.
11 Jun, 2021 | 08:15h | UTCCommentary: Is Thoracentesis Safe in Coagulopathic Patients? – JournalFeed
M-A: Mental health interventions may improve psychological outcomes in informal caregivers of critically ill patients.
11 Jun, 2021 | 08:14h | UTC
Commentary on Twitter
https://twitter.com/stephanajulia/status/1381591004776595458
The furosemide stress test: current use and future potential.
11 Jun, 2021 | 08:12h | UTCThe furosemide stress test: current use and future potential – Renal Failure
Case series: Adjunct immune globulin for vaccine-induced thrombotic thrombocytopenia.
10 Jun, 2021 | 09:46h | UTC
[Preprint] RECOVERY trial finds aspirin does not improve survival for patients hospitalized with COVID-19.
9 Jun, 2021 | 08:28h | UTCNews Release: RECOVERY trial finds aspirin does not improve survival for patients hospitalised with COVID-19 – University of Oxford
Original Study: Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial – medRxiv
Commentary on Twitter (thread – click for more)
RECOVERY Pre-print: Aspirin
14,892 patients randomised to aspirin vs. usual care
– no impact on all-cause mortality (17% vs. 17%)
– similar results in all pre-specified subgroupshttps://t.co/ay5Xg4GBVD pic.twitter.com/aNJ09RTTOa— Martin Landray (@MartinLandray) June 8, 2021
COVID-19 Imaging: What we know now and what remains unknown.
9 Jun, 2021 | 08:27h | UTCCOVID-19 Imaging: What We Know Now and What Remains Unknown – Radiology
M-A: Hospital-at-home interventions for patients with chronic disease who present to the emergency department – similar mortality risk, lower risk for readmission, lower depression and anxiety scores, and a lower risk for long-term care admission vs. in-hospital stay.
9 Jun, 2021 | 08:20h | UTCInvited commentary: Hospitalization at Home for Patients With Acute Exacerbation of Chronic Disease—Further Evidence to Inform Practice – JAMA Network Open
Related: Pandemic Boosts an Old Idea—Bringing Acute Care to the Patient AND Randomized trial: Admission Avoidance Hospital at Home + Geriatric Assessment led to similar outcomes compared to hospital admission for older persons AND Most COVID-19 patients receiving home-based hospital care did not require escalation to traditional hospital setting – Approximately 1 in 5 were admitted within 14 days. Higher oxygen saturation was associated with decreased odds of transfer, whereas higher comorbidity burden was associated with increased risk.
Short review: Neurological complications of COVID-19.
8 Jun, 2021 | 09:36h | UTCNeurological complications of COVID-19 – Intensive Care Medicine
Commentary on Twitter
NeuroCOVID potential mechanism(s)?
🧠 #COVID19 neuro-complications
🧠 direct neuroinvasion
🧠 inflammatory/autoimmune
🧠 vascular
+
🧠 #ICU complications
🧠 drugs toxicity/side effects
🧠 PICS/PACS & PTSD
Challenging to identify/diagnose: strictly monitor! https://t.co/0YlAoanUFo pic.twitter.com/unM0SWFR7L— Intensive Care Medicine (@yourICM) June 7, 2021
The “Black Fungus” in India: The Emerging Syndemic of COVID-19–Associated Mucormycosis – careful use of antibiotics and corticosteroids and closely monitoring blood glucose levels are some of the strategies suggested by the authors.
8 Jun, 2021 | 09:34h | UTC
Multicenter Epidemiologic Study of Coronavirus Disease–Associated Mucormycosis, India – Uncontrolled diabetes mellitus was the most common underlying disease; improper glucocorticoid use was independently associated with the disease.
8 Jun, 2021 | 09:33h | UTCCommentary: COVID19: Secondary Infections Still a Big Challenge in India – News Click
Commentary on Twitter
New study from India on mucormycosis
– COVID-19 has led to increases in mucormycosis, partly from inappropriate steroid use
– Uncontrolled diabetes was the most common underlying disease
Better diabetes care & rational steroid use are key!https://t.co/Wv8kCyTDtK pic.twitter.com/KK78BKg2Xf
— Madhu Pai, MD, PhD (@paimadhu) June 7, 2021
Time-to-positivity in bloodstream infection is not a prognostic marker for mortality: analysis of a prospective multicenter randomized control trial.
8 Jun, 2021 | 09:21h | UTC
Commentary on Twitter
🆕💥Analysis Data from RAPIDO RCT
Time to positivity is not associated with mortality, except in Candida spp (longer times associated with worse outcomes), and possibly in Streptococci (shorter times associated with worse outcomes) #IDTwitter #medtwitter https://t.co/v17uT8j7u9— Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 (@ABsteward) June 7, 2021
RCT: In patients hospitalized with Covid-19 with elevated D-Dimer, a full-dose anticoagulation strategy based on rivaroxaban (full-dose heparins in unstable patients) + rivaroxaban to day 30 was not better than prophylactic anticoagulation and increased bleeding risk.
7 Jun, 2021 | 00:01h | UTC
Commentary on Twitter
https://twitter.com/RenatoDLopes1/status/1400962037610582026
Case report: Successful treatment of vaccine-induced prothrombotic immune thrombocytopenia (VIPIT).
6 Jun, 2021 | 23:55h | UTC
RCT: Early, intensive mobilization poststroke may harm patients.
6 Jun, 2021 | 23:45h | UTCFatal and Nonfatal Events Within 14 days After Early, Intensive Mobilization Poststroke – Neurology
Moving from bytes to bedside: a systematic review on the use of artificial intelligence in the intensive care unit.
6 Jun, 2021 | 23:42h | UTC
Commentary on Twitter
Overview of current maturity of using #ArtificialIntelligence in #ICU, research methodologies, risk of bias: SR including 494 studies. To date, vast majority of published ICU #AI models remain in prototyping/development environment, not tested at bedside. https://t.co/kTpSy2Is7J https://t.co/oU11J3XYjA pic.twitter.com/tKIwQYqgRH
— Intensive Care Medicine (@yourICM) June 5, 2021
M-A: The benefit of dysphagia screening in adult patients with stroke.
6 Jun, 2021 | 23:43h | UTC
Another study shows a high frequency of antibiotic use among patients hospitalized with Covid-19 (85.2%), despite low rates of confirmed secondary bacterial infections.
4 Jun, 2021 | 10:43h | UTCCommentaries: Very high use of antibiotics in COVID-19 treatment could be reduced – University of Glasgow AND More evidence of frequent antibiotic use noted in COVID patients – CIDRAP AND Covid-19: Antimicrobial use was high during first wave despite bacterial co-infections being rare, study finds – The BMJ
Related: Many hospitalized Covid-19 patients are given antibiotics. That’s a problem – STAT
Commentary on Twitter (thread – click for more)
Our paper on co-infections, secondary infections & antimicrobial use in patients hospitalised with #COVID19 in UK during the 1st wave is out in @LancetMicrobe!@ISARIC1 @CCPUKstudy @CVRinfo @UofGlasgow @EdinburghUni @LivUni @imperialcollege https://t.co/QYU1B2Eyup
A🧵
— Antonia Ho (@DrToniHo) June 3, 2021
M-A: Prehospital Tranexamic Acid reduces mortality among bleeding trauma patients without increasing the risk of venous thromboembolism.
6 Jun, 2021 | 23:34h | UTCThe impact of prehospital TXA on mortality among bleeding trauma patients: A systematic review and meta-analysis – Journal of Trauma and Acute Care Surgery (link to abstract – $ for full-text)
Commentary: Prehospital TXA for Trauma – Meta-analysis – JournalFeed
In a Mendelian randomization study, researchers found no genetic evidence to support an association between Vitamin D levels and COVID-19 susceptibility, severity, or hospitalization.
4 Jun, 2021 | 10:35h | UTCCommentary: Vitamin D may not provide protection from COVID-19 susceptibility or disease severity, study suggests – PLOS
Related: Living systematic review: The evidence is insufficient to determine the benefits and harms of vitamin D supplementation as a treatment of COVID‐19. AND RCT: Vitamin D3 does not improve outcomes in hospitalized patients with moderate to severe COVID-19
Target arterial PO2 according to the underlying pathology: a mini-review of the available data in mechanically ventilated patients.
4 Jun, 2021 | 10:26h | UTC
RCT: No benefit from passive leg raising during cardiopulmonary resuscitation in out-of-hospital cardiac arrest.
4 Jun, 2021 | 10:28h | UTC
Commentary on Twitter
Recently released in @Crit_Care our passive leg raising out-of-hospital cardiac arrest randomized controlled trial
Neutral results in survival and no evidence of adverse effects @eneko70 @alfredobardaji @mjimenezherrera https://t.co/dyxCJAB4bG— Youcef Azeli (@YoucefAzeli) May 25, 2021


